pharma · Colorectal Cancer · Lymphoma, Extranodal NK-T-Cell
Samsung Bioepis
Samsung Bioepis NL B.V.
Samsung Bioepis is a pharma organization headquartered in KR. Primary therapeutic focus areas include Colorectal Cancer, Lymphoma, Extranodal NK-T-Cell, Cancer of Stomach, Dyspepsia, Depression. NovaPharmaNews links 24 c
Yeonsu-gu, Incheon 21987, KR HQ
2012 Founded
1,589 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Yeonsu-gu, Incheon 21987, KR
- Founded
- 2012
- Employees
- 1,589
- Programs
- 24
- Drugs
- 34
- Patents
- 0
PNEUMOSTEM®
Phase 1 · mab · Pulmonary Arterial Hypertension (PAH)
PNEUMOSTEM® for Pulmonary Arterial Hypertension (PAH) is a Phase 1 program (mab) at Samsung Bioepis NL B.V. with 1 ClinicalTrials.gov record(s).
Internal code 2025-10-080
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Samsung Bioepis NL B.V.
- Phase
- Phase 1
- Modality
- mab
- Indication
- Pulmonary Arterial Hypertension (PAH)
- Status
- active
- Trials
- 1